Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 586

1.

Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.

Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R; National Institutes of Health Breast Cancer Surveillance Consortium.

J Natl Cancer Inst. 2007 Mar 7;99(5):386-95.

2.

Are breast density and bone mineral density independent risk factors for breast cancer?

Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR.

J Natl Cancer Inst. 2005 Mar 2;97(5):368-74.

3.

Prospective breast cancer risk prediction model for women undergoing screening mammography.

Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.

J Natl Cancer Inst. 2006 Sep 6;98(17):1204-14.

4.

Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.

Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V.

J Natl Cancer Inst. 1997 Jan 1;89(1):76-82.

5.

Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.

Tice JA, Cummings SR, Ziv E, Kerlikowske K.

Breast Cancer Res Treat. 2005 Nov;94(2):115-22.

PMID:
16261410
6.

Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.

Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilacqua G, Bartolozzi C.

Radiol Med. 2007 Mar;112(2):272-86. Epub 2007 Mar 19. English, Italian.

PMID:
17361370
7.

Mammographic density and estimation of breast cancer risk in intermediate risk population.

Tesic V, Kolaric B, Znaor A, Kuna SK, Brkljacic B.

Breast J. 2013 Jan-Feb;19(1):71-8. doi: 10.1111/tbj.12051. Epub 2012 Nov 23.

PMID:
23173778
8.

Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.

Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE.

Radiology. 2012 Oct;265(1):59-69. Epub 2012 Jun 21.

PMID:
22723501
9.

Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.

Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E.

J Natl Cancer Inst. 2000 Jul 5;92(13):1081-7.

10.

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR.

Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.

11.

Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women.

Venturini E, Losio C, Panizza P, Rodighiero MG, Fedele I, Tacchini S, Schiani E, Ravelli S, Cristel G, Panzeri MM, De Cobelli F, Del Maschio A.

Radiology. 2013 Aug;268(2):347-55. doi: 10.1148/radiol.13122278. Epub 2013 Apr 11.

PMID:
23579052
13.

Revisiting the mammographic follow-up of BI-RADS category 3 lesions.

Varas X, Leborgne JH, Leborgne F, Mezzera J, Jaumandreu S, Leborgne F.

AJR Am J Roentgenol. 2002 Sep;179(3):691-5.

PMID:
12185047
14.

Biennial versus annual mammography and the risk of late-stage breast cancer.

White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, Ballard-Barbash R, Taplin SH.

J Natl Cancer Inst. 2004 Dec 15;96(24):1832-9.

15.

Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.

Baum JK, Hanna LG, Acharyya S, Mahoney MC, Conant EF, Bassett LW, Pisano ED.

Radiology. 2011 Jul;260(1):61-7. doi: 10.1148/radiol.11101285. Epub 2011 Apr 18.

16.

Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.

Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith-Bindman R, Lehman C, Weaver D, Carney PA, Barlow WE.

J Natl Cancer Inst. 2010 Jul 21;102(14):1040-51. doi: 10.1093/jnci/djq233. Epub 2010 Jul 2.

17.

The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.

Olson JE, Sellers TA, Scott CG, Schueler BA, Brandt KR, Serie DJ, Jensen MR, Wu FF, Morton MJ, Heine JJ, Couch FJ, Pankratz VS, Vachon CM.

Breast Cancer Res. 2012 Nov 15;14(6):R147. doi: 10.1186/bcr3357.

18.

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Bandos H, Weissfeld JL, Wolmark N.

Cancer Prev Res (Phila). 2012 Nov;5(11):1321-9. doi: 10.1158/1940-6207.CAPR-12-0273. Epub 2012 Oct 11.

19.

Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?

Uematsu T, Yuen S, Kasami M, Uchida Y.

Breast Cancer Res Treat. 2007 Jul;103(3):269-81. Epub 2006 Oct 25.

PMID:
17063274
20.

A prospective study of breast cancer risk using routine mammographic breast density measurements.

Vacek PM, Geller BM.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):715-22.

Items per page

Supplemental Content

Write to the Help Desk